PMID- 25678692 OWN - NLM STAT- MEDLINE DCOM- 20150903 LR - 20221207 IS - 1552-5783 (Electronic) IS - 0146-0404 (Print) IS - 0146-0404 (Linking) VI - 56 IP - 3 DP - 2015 Feb 12 TI - In Vivo Role of TLR2 and MyD88 Signaling in Eliciting Innate Immune Responses in Staphylococcal Endophthalmitis. PG - 1719-32 LID - 10.1167/iovs.14-16087 [doi] AB - PURPOSE: The purpose of this study was to investigate the protective mechanisms evoked by TLR2 and MyD88 signaling in bacterial endophthalmitis in vivo. METHODS: Endophthalmitis was induced in wild-type (WT), TLR2(-/-), MyD88(-/-), and Cnlp(-/-) mice by intravitreal injections of a laboratory strain (RN6390) and two endophthalmitis isolates of Staphylococcus aureus. Disease progression was monitored by assessing corneal and vitreous haze, bacterial burden, and retinal tissue damage. Levels of inflammatory cytokines/chemokines were determined using quantitative RT-PCR (qRT-PCR) and ELISA. Flow cytometry was used to assess neutrophil infiltration. Cathelicidin-related antimicrobial peptide (CRAMP) expression was determined by immunostaining and dot blot. RESULTS: Eyes infected with either laboratory or clinical isolates exhibited higher levels of inflammatory mediators at the early stages of infection (48 hours), coinciding with increased bacterial burden and retinal damage. Both TLR2(-/-) and MyD88(-/-) retinas produced reduced levels of CRAMP, and its deficiency (Cnlp(-/-)) rendered the mice susceptible to increased bacterial burden and retinal tissue damage as early as 1 day post infection. Analyses of inflammatory mediators and neutrophil levels in WT versus Cnlp(-/-) mice showed a trend similar to that observed in TLR2 and MyD88 KO mice. Furthermore, we observed that even a 10-fold lower infective dose of S. aureus was sufficient to cause endophthalmitis in TLR2(-/-) and MyD88(-/-) mice. CONCLUSIONS: TLR2 and MyD88 signaling plays an important role in protecting the retina from staphylococcal endophthalmitis by production of the antimicrobial peptide CRAMP. CI - Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc. FAU - Talreja, Deepa AU - Talreja D AD - Department of Ophthalmology/Kresge Eye Institute, Wayne State University, Detroit, Michigan, United States Department of Biological Sciences, Oakland University, Rochester, Michigan, United States. FAU - Singh, Pawan Kumar AU - Singh PK AD - Department of Ophthalmology/Kresge Eye Institute, Wayne State University, Detroit, Michigan, United States Department of Anatomy and Cell Biology, Wayne State University, Detroit, Michigan, United States. FAU - Kumar, Ashok AU - Kumar A AD - Department of Ophthalmology/Kresge Eye Institute, Wayne State University, Detroit, Michigan, United States. LA - eng GR - P30 EY004068/EY/NEI NIH HHS/United States GR - R01 EY019888/EY/NEI NIH HHS/United States GR - EY19888/EY/NEI NIH HHS/United States GR - P30EY004068/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20150212 PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 RN - 0 (Antimicrobial Cationic Peptides) RN - 0 (Cathelicidins) RN - 0 (Chemokines) RN - 0 (Cytokines) RN - 0 (Myd88 protein, mouse) RN - 0 (Myeloid Differentiation Factor 88) RN - 0 (Tlr2 protein, mouse) RN - 0 (Toll-Like Receptor 2) SB - IM MH - Animals MH - Antimicrobial Cationic Peptides MH - Cathelicidins/metabolism MH - Chemokines/metabolism MH - Cytokines/metabolism MH - Endophthalmitis/*genetics/*immunology/pathology MH - Immunity, Innate/*genetics/*immunology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Myeloid Differentiation Factor 88/*genetics MH - Retina/immunology/pathology MH - Signal Transduction/*genetics MH - Staphylococcal Infections/*genetics/*immunology/pathology MH - Toll-Like Receptor 2/*genetics PMC - PMC4356198 OTO - NOTNLM OT - CRAMP OT - MyD88 OT - Staphylococcus aureus OT - TLR2 OT - endophthalmitis OT - inflammation OT - retinal damage EDAT- 2015/02/14 06:00 MHDA- 2015/09/04 06:00 PMCR- 2015/09/01 CRDT- 2015/02/14 06:00 PHST- 2015/02/14 06:00 [entrez] PHST- 2015/02/14 06:00 [pubmed] PHST- 2015/09/04 06:00 [medline] PHST- 2015/09/01 00:00 [pmc-release] AID - iovs.14-16087 [pii] AID - IOVS-14-16087 [pii] AID - 10.1167/iovs.14-16087 [doi] PST - epublish SO - Invest Ophthalmol Vis Sci. 2015 Feb 12;56(3):1719-32. doi: 10.1167/iovs.14-16087.